Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mannosidase alpha class 1A member 1 (MAN1A1) is a Golgi-localized enzyme belonging to the glycosyl hydrolase 47 family, primarily responsible for the early stages of N-glycan processing [UniProt: P33907]. It specifically catalyzes the removal of alpha-1,2-linked mannose residues from Man9GlcNAc2 to produce Man6GlcNAc2, a critical step for the subsequent synthesis of complex and hybrid N-glycans [NCBI Gene: 4121]. In oncology, MAN1A1 is recognized for its role in regulating the glyco-checkpoint; its downregulation is frequently observed in aggressive cancers like breast and hepatocellular carcinoma, leading to an accumulation of high-mannose glycans that promote tumor cell migration and immune evasion [PMID: 29453315, PMID: 24607494]. While small molecule inhibitors such as kifunensine are widely used in research to block this pathway, therapeutic strategies targeting MAN1A1 mRNA via RNA interference (RNAi) or antisense oligonucleotides are being explored to modulate glycan-dependent signaling in the tumor microenvironment [PMID: 31515460]. Understanding the balance of MAN1A1 activity is crucial, as its dysregulation significantly impacts the stability and function of various cell surface receptors, including integrins and growth factor receptors [PMID: 25666607]. Furthermore, MAN1A1 expression levels serve as potential prognostic biomarkers in several malignancies, reflecting the metabolic state of the cell's glycosylation machinery.
Inhibition of alpha-1,2-mannosidase activity or reduction of MAN1A1 expression to modulate N-glycan maturation and cell surface glycan profiles.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannosidase alpha class 1A member 1 (MAN1A1).